Clinical Trial Update: Safety and Efficacy Study of Pirfenidone to Treat Grade 2 or Above Radiation-induced Lung Injury [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of pirfenidone for radiation-induced lung injury (radiation pneumonitis) with current status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Pneumonitis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Radiation Pneumonitis | Phase 2 | Status: UNKNOWN